Coronavirus: Facts Vs Myths | Covaxin Safe, Phase 3 Results Needed: Lancet

Covid-19 News: Covaxin, the homegrown coronavirus vaccine that was authorised for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its Phase 2 results. Medical journal Lancet has said that efficacy cannot be determined by Phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is "safe/immunogenic". The Lancet report says the results reported in the study of Phase 2 results do not permit efficacy assessments and further corroboration with Phase 3 safety results was required.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt